BRAF and malignant colon neoplasm: However, MAPKi combination treatment induced cell death and reduced cell numbers in a synergistic manner in BRAF mutant melanoma cell lines, but not in the BRAF mutant/MITF-negative colon cancer cell line RKO (Figures 6A and 6B).